Bayer AG Stock CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Stocks
BAYNd
DE000BAY0017
Pharmaceuticals
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.65 EUR | -0.63% |
|
+2.48% | -33.31% |
| 04:37pm | AlphaValue/Baader Europe Downgrades Bayer to Add, Lifts PT | MT |
| 04:15pm | Genetic engineering in the supermarket: EU loosens rules | DP |
| Market Cap | 37.08B 42.98B 34.09B 32.08B 60.29B 4,056B 60.8B 404B 157B 1,991B 161B 158B 6,886B | P/E 2026 * |
16x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 68.77B 79.72B 63.23B 59.51B 112B 7,523B 113B 749B 292B 3,692B 299B 293B 12,773B | EV / Sales 2026 * |
1.51x | EV / Sales 2027 * | 1.4x |
| Free-Float |
100% | Yield 2026 * |
0.59% | Yield 2027 * | 1.96% |
Last Transcript: Bayer AG
| 1 week | +6.94% | ||
| Current month | +4.50% | ||
| 1 month | +0.70% | ||
| 3 months | -5.89% | ||
| 6 months | +8.01% | ||
| Current year | +2.42% |
| 1 week | 35.44 |  | 38.58 |
| 1 month | 32.9 | | 39.46 |
| 3 years | 18.39 | | 53.79 |
| 5 years | 18.39 | | 67.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 01/06/2023 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 01/06/2026 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 01/04/2012 |
| Director/Board Member | 66 | 01/04/2022 | |
Heike Hausfeld
BRD | Director/Board Member | 60 | 01/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | +2.48% | +40.05% | -27.46% | 42.98B | |
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | |
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | |
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | |
| -1.09% | +0.68% | +24.66% | +16.53% | 330B | |
| -0.40% | -1.27% | +27.10% | +15.11% | 280B | |
| -0.75% | -1.18% | +26.46% | +32.20% | 279B | |
| -1.59% | -0.37% | -41.66% | -48.01% | 196B | |
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | |
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | |
| Average | -0.42% | +0.41% | +22.41% | +34.68% | 374.58B | |
| Weighted average by Cap. | -0.30% | -0.49% | +29.42% | +64.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.54B 52.79B 41.87B 39.41B 74.05B 4,982B 74.67B 496B 193B 2,445B 198B 194B 8,458B | 46.81B 54.26B 43.03B 40.51B 76.11B 5,121B 76.75B 510B 199B 2,513B 204B 199B 8,694B |
| Net income | 2.17B 2.52B 2B 1.88B 3.53B 238B 3.56B 23.66B 9.21B 117B 9.45B 9.25B 403B | 3B 3.47B 2.75B 2.59B 4.87B 328B 4.91B 32.64B 12.71B 161B 13.03B 12.76B 556B |
| Net Debt | 31.7B 36.74B 29.14B 27.43B 51.54B 3,467B 51.97B 345B 134B 1,702B 138B 135B 5,887B | 28.63B 33.18B 26.32B 24.77B 46.55B 3,131B 46.94B 312B 121B 1,537B 125B 122B 5,317B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change |
|---|---|---|
| 18/06/26 | 37.65 € | -0.63% |
| 17/06/26 | 37.89 € | +5.37% |
| 16/06/26 | 35.96 € | -0.50% |
| 15/06/26 | 36.14 € | -0.14% |
| 12/06/26 | 36.19 € | +0.72% |
- Stock Market
- Stocks
- BAYN Stock
- BAYNd Stock
Select your edition
All financial news and data tailored to specific country editions
